Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Cancergenetik i Stockholm AB

Closing information (x1000 NOK)

Closing information 2024/03 2023/03 2022/03
Turnover 0 More Arrow 1,474 More Arrow 1,874
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -299 More Arrow 311 Less Arrow 269
EBITDA -302 More Arrow 311 Less Arrow 269
Total assets 562 More Arrow 744 Less Arrow 423
Current assets 562 More Arrow 744 Less Arrow 423
Current liabilities 197 Less Arrow 76 Less Arrow 23
Equity capital 365 More Arrow 637 Less Arrow 387
- share capital 51 Less Arrow 50 Less Arrow 47
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2024/03 2023/03 2022/03
Solvency 64.9% More Arrow 85.6% More Arrow 91.5%
Turnover per employee 0 More Arrow 1,474 More Arrow 1,874
Profit as a percentage of turnover 21.1% Less Arrow 14.4%
Return on assets (ROA) -53.2% More Arrow 41.8% More Arrow 63.6%
Current ratio 285.3% More Arrow 978.9% More Arrow 1839.1%
Return on equity (ROE) -81.9% More Arrow 48.8% More Arrow 69.5%
Change turnover -1,489 More Arrow -550 More Arrow -36
Change turnover % -100% More Arrow -27% More Arrow -2%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/03 2023/03 2022/03
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.